Skip to main content
OpenTrials
Completed

NCT Number: NCT00641446

Varicella Vaccination With Pulmicort

A study to determine whether treatment with Pulmicort in children has any effect on the varicella vaccine

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children between the age of 10 months and 8 years,
  • have asthma or shown recent signs suggesting asthma,
  • have a parent or guardian willing to comply with study requirements

Exclusion criteria

  • Varicella zoster immune globulin (VZIG) within 5 months prior to immunization,
  • Previous varicella immunization,
  • an immunization or allergy immunotherapy 4 weeks prior to immunization,
  • Severe asthma,
  • have another persistent lung disease,
  • have a planned hospitalization for the duration of study

Treatment and study plan

Budesonide

Drug

Other names: Pulmicort

varicella zoster virus

Drug

Other names: Varivax

Primary outcomes

  1. Seroconversion level

    Time frame: Week 6

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Rates of Seroconversion Following Varicella Vaccination of Asthmatic Children Between the Ages of One and Eight Years Treated With Pulmicort Respules® Versus Non-Steroidal Conventional Asthma Therapy

Important dates

Study start
2001
Primary completion
2003
Study completion
2003
First posted
Mar 24, 2008
Registry last updated
Mar 25, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.